Literature DB >> 15116608

The mini-incision approach to total hip arthroplasty.

Thomas P Sculco1, Louis C Jordan.   

Abstract

Total hip arthroplasty (THA) usually involves an incision of approximately 20 to 25 cm long. Surgeons recently have begun to question the need for such a long incision and are developing less invasive approaches to THA. A mini-incision approach to THA promotes shorter hospital stays, faster rehabilitation, and an increase in patient satisfaction without a detrimental effect on outcome. The surgical technique is based on the classic Moore approach to the hip. The incisions measure 6 to 10 cm in length, and the surgery involves significantly less deep soft-tissue disruption. All the basic tenets of THA are respected and visualization is maintained throughout the procedure for proper placement of the components. Mini-incision THA offers a safe and effective alternative to THA performed through a larger incision. Obese patients typically are not good candidates. Patients with severe hip dysplasia or those undergoing revision surgery require a wider exposure to perform the arthroplasty to ensure the best possible result. In properly selected patients, however, THA can be performed through an abridged mini-incision without compromising the results or exposing the patient to additional risk.

Entities:  

Mesh:

Year:  2004        PMID: 15116608

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN: 0065-6895


  3 in total

Review 1.  [Precision in orthopaedic computer navigation].

Authors:  T Hüfner; D Kendoff; M Citak; J Geerling; C Krettek
Journal:  Orthopade       Date:  2006-10       Impact factor: 1.087

2.  Intraoperative dislocation of a trial femoral head into the pelvis during total hip arthroplasty.

Authors:  Yaron Bar Ziv; David Backstein; Oleg Safir; Yona Kosashvili
Journal:  Can J Surg       Date:  2008-06       Impact factor: 2.089

Review 3.  Posterior single-incision approach to minimally invasive total hip arthroplasty.

Authors:  T V Swanson
Journal:  Int Orthop       Date:  2007-08       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.